{"id":"W2083415436","doi":"10.1111/j.1463-1326.2011.01493.x","title":"Achieving a clinically relevant composite outcome of an HbA1c of <7% without weight gain or hypoglycaemia in type 2 diabetes: a meta‐analysis of the liraglutide clinical trial programme","year":2011,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":120,"is_retracted":false,"has_abstract":true,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"Merck Sharp and Dohme; Novo Nordisk","keywords":"Liraglutide; Medicine; Sitagliptin; Glimepiride; Exenatide; Type 2 diabetes; Internal medicine; Weight loss; Rosiglitazone; Weight gain; Placebo; Diabetes mellitus; Endocrinology; Obesity","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.005138553,0.0008421239,0.0133064,0.0009386532,0.00006308634,0.00002661678,0.0007426803,0.0006579502,0.00007917055],"category_scores_gemma":[0.001263577,0.0004603377,0.004640534,0.002068742,0.0006310013,0.0001507348,0.0005384649,0.0007884086,0.000003514734],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003800797,"about_ca_system_score_gemma":0.0002927146,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005991661,"about_ca_topic_score_gemma":0.00008219697,"domain_scores_codex":[0.9913785,0.001774122,0.004537857,0.0009644339,0.0006014268,0.0007436279],"domain_scores_gemma":[0.9933177,0.001426906,0.002997316,0.001646076,0.0002699496,0.0003420238],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.003079908,0.008197237,0.20022,0.02130282,0.2482099,0.000013859,0.0002623112,0.000001482615,0.00001157805,0.0004959558,0.00002388931,0.5181811],"study_design_scores_gemma":[0.01431743,0.002049755,0.05148708,0.0031076,0.8185086,5.869796e-7,0.00001722103,0.00006467793,0.00003148891,0.00005480239,0.1097481,0.0006126661],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.3495661,0.6466147,0.000001846846,0.00002226937,0.000359332,0.003149641,0.0001169173,0.00002859547,0.0001406503],"genre_scores_gemma":[0.02911554,0.9661091,0.003443241,0.0001760909,0.0001818735,0.0002693884,0.0002514542,0.00009559129,0.0003577576],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.5702987,"threshold_uncertainty_score":0.9997848,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1609040643722358,"score_gpt":0.3953648381021613,"score_spread":0.2344607737299255,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}